Syrbactin-class dual constitutive- and immuno-proteasome inhibitor TIR-199 impedes myeloma-mediated bone degeneration in vivo.
- Published in:
- Bioscience Reports, 2022, v. 42, n. 2, p. 1, doi. 10.1042/BSR20212721
- By:
- Publication type:
- Article
Works matching IS 01448463 AND DT 2022 AND VI 42 AND IP 2
Results: 15
1
2
Acanthopanax senticosus total flavonoids alleviate lipopolysaccharide-induced intestinal inflammation and modulate the gut microbiota in mice.
- Published in:
- Bioscience Reports, 2022, v. 42, n. 2, p. 1, doi. 10.1042/BSR20212670
- By:
- Publication type:
- Article
3
Polymeric biocompatible iron oxide nanoparticles labeled with peptides for imaging in ovarian cancer.
- Published in:
- Bioscience Reports, 2022, v. 42, n. 2, p. 1, doi. 10.1042/BSR20212622
- By:
- Publication type:
- Article
4
Single-cell transcriptomics analysis reveals intratumoral heterogeneity and identifies a gene signature associated with prognosis of hepatocellular carcinoma.
- Published in:
- Bioscience Reports, 2022, v. 42, n. 2, p. 1, doi. 10.1042/BSR20212560
- By:
- Publication type:
- Article
5
Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
- Published in:
- Bioscience Reports, 2022, v. 42, n. 2, p. 1, doi. 10.1042/BSR20212523
- By:
- Publication type:
- Article
6
Role of ACSL4 in the chemical-induced cell death in human proximal tubule epithelial HK-2 cells.
- Published in:
- Bioscience Reports, 2022, v. 42, n. 2, p. 1, doi. 10.1042/BSR20212433
- By:
- Publication type:
- Article
7
Current progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma.
- Published in:
- Bioscience Reports, 2022, v. 42, n. 2, p. 1, doi. 10.1042/BSR20212304
- By:
- Publication type:
- Article
8
IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma.
- Published in:
- Bioscience Reports, 2022, v. 42, n. 2, p. 1, doi. 10.1042/BSR20212119
- By:
- Publication type:
- Article
9
Comprehensive characterization of the alternative splicing landscape in ovarian cancer reveals novel events associated with tumor-immune microenvironment.
- Published in:
- Bioscience Reports, 2022, v. 42, n. 2, p. 1, doi. 10.1042/BSR20212090
- By:
- Publication type:
- Article
10
Identification of potential immunotherapy biomarkers for breast cancer by bioinformatics analysis.
- Published in:
- Bioscience Reports, 2022, v. 42, n. 2, p. 1, doi. 10.1042/BSR20212035
- By:
- Publication type:
- Article
11
Probing altered enzyme activity in the biochemical characterization of cancer.
- Published in:
- Bioscience Reports, 2022, v. 42, n. 2, p. 1, doi. 10.1042/BSR20212002
- By:
- Publication type:
- Article
12
Lassa virus glycoprotein complex review: insights into its unique fusion machinery.
- Published in:
- Bioscience Reports, 2022, v. 42, n. 2, p. 1, doi. 10.1042/BSR20211930
- By:
- Publication type:
- Article
13
Multimerin-1 and cancer: a review.
- Published in:
- Bioscience Reports, 2022, v. 42, n. 2, p. 1, doi. 10.1042/BSR20211248
- By:
- Publication type:
- Article
14
Mycobacterium tuberculosis carbon and nitrogen metabolic fluxes.
- Published in:
- Bioscience Reports, 2022, v. 42, n. 2, p. 1, doi. 10.1042/BSR20211215
- By:
- Publication type:
- Article
15
The anti-tumor effects of the combination of microwave hyperthermia and lobaplatin against breast cancer cells in vitro and in vivo.
- Published in:
- Bioscience Reports, 2022, v. 42, n. 2, p. 1, doi. 10.1042/BSR20190878
- By:
- Publication type:
- Article